While the study found that neither intervention significantly increased vaccine uptake, more participants took the vaccine ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
Legislation heading to Gov. JB Pritzker's desk could make Illinois the first state to issue vaccine recommendations ...
Among the most commonly cited reasons for COVID vaccine hesitation are fears about side effects, long-term health ...
10h
NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position
NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2025 with the Securities and Exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback